Concepedia

Dan H. Moore

DH

Statistics

Publications

378

Citations

30.4K

H-Index

94

Active since

1940

Affiliations

University of California, San Francisco(Current)

California Pacific Medical Center

Lawrence Livermore National Laboratory

Columbia University

Coriell Institute For Medical Research

Dan H. Moore is an author at University of California, San Francisco specializing in medicine, pathology, and cell biology.

ORCID

Top concepts

Publications per year

1940–2023

378

Publications

378

Tumor Angiogenesis: A New Significant and Independent Prognostic Indicator in Early-Stage Breast Carcinoma

Noel Weidner, J Folkman, F. Pozza et al. · JNCI Journal of the National Cancer Institute · 1992 · 1.8K citations

Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)

Robert G. Miller, John D. Mitchell, Dan H. Moore · Cochrane Database of Systematic Reviews · 2012 · 1K citations · Full text

Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast Cancers

Ann D. Thor, Dan H. Moore, S M Edgerton et al. · JNCI Journal of the National Cancer Institute · 1992 · 733 citations

Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.

John W. Park, Keelung Hong, Dmitri B. Kirpotin et al. · PubMed · 2002 · 648 citations

Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial

Dan H. Moore, Robert G. Miller, Julaine Florence et al. · The Lancet Neurology · 2007 · 637 citations

, , +4

1–5 of 378